191 related articles for article (PubMed ID: 34267303)
1. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
Roh TH; Kang SG; Moon JH; Sung KS; Park HH; Kim SH; Kim EH; Hong CK; Suh CO; Chang JH
J Neurosurg; 2019 Mar; 132(3):895-901. PubMed ID: 30835701
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.
Hirono S; Hasegawa Y; Sakaida T; Uchino Y; Hatano K; Iuchi T
Sci Rep; 2019 Nov; 9(1):17794. PubMed ID: 31780768
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
Yoo J; Yoon SJ; Kim KH; Jung IH; Lim SH; Kim W; Yoon HI; Kim SH; Sung KS; Roh TH; Moon JH; Park HH; Kim EH; Suh CO; Kang SG; Chang JH
J Neurosurg; 2022 Aug; 137(2):533-543. PubMed ID: 34972087
[TBL] [Abstract][Full Text] [Related]
5. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A
J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795
[TBL] [Abstract][Full Text] [Related]
6. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
[TBL] [Abstract][Full Text] [Related]
7. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
8. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
Ene CI; Cimino PJ; Fine HA; Holland EC
Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
[TBL] [Abstract][Full Text] [Related]
9. Supratotal Resection of Glioblastoma: Better Survival Outcome than Gross Total Resection.
Baik SH; Kim SY; Na YC; Cho JM
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983564
[TBL] [Abstract][Full Text] [Related]
10. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
[TBL] [Abstract][Full Text] [Related]
11. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.
Tsien CI; Brown D; Normolle D; Schipper M; Piert M; Junck L; Heth J; Gomez-Hassan D; Ten Haken RK; Chenevert T; Cao Y; Lawrence T
Clin Cancer Res; 2012 Jan; 18(1):273-9. PubMed ID: 22065084
[TBL] [Abstract][Full Text] [Related]
12. Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis.
Incekara F; Koene S; Vincent AJPE; van den Bent MJ; Smits M
World Neurosurg; 2019 Jul; 127():617-624.e2. PubMed ID: 31004858
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
14. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
Jiang H; Zeng W; Ren X; Cui Y; Li M; Yang K; Elbaroody M; Lin S
J Neurooncol; 2019 Aug; 144(1):127-135. PubMed ID: 31175579
[TBL] [Abstract][Full Text] [Related]
15. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.
Jackson C; Choi J; Khalafallah AM; Price C; Bettegowda C; Lim M; Gallia G; Weingart J; Brem H; Mukherjee D
J Neurooncol; 2020 Jul; 148(3):419-431. PubMed ID: 32562247
[TBL] [Abstract][Full Text] [Related]
17. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
[TBL] [Abstract][Full Text] [Related]
18. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.
Matsuda M; Kohzuki H; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Mizumoto M; Tsuboi K; Matsumura A
J Clin Neurosci; 2018 Apr; 50():172-176. PubMed ID: 29396060
[TBL] [Abstract][Full Text] [Related]
19. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
